Mindfulness meditation in virtual reality to help stop smoking
Official title: Effects of Mindfulness Meditation in Virtual Reality on Craving and Smoking Cessation
Run by Centre Hospitalier Henri Laborit · NCT05766553 · Data updated 2026-11-12
This study is testing if mindfulness meditation in virtual reality can help people who want to quit smoking by reducing cravings and preventing them from going back to smoking.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Centre Hospitalier Henri Laborit Academic / other |
| Locations | 3 sites (Iteuil and 2 other locations) |
| Status | Recruiting |
| Started | June 15, 2023 |
| Main results expected | October 15, 2026 |
| Study ends | December 15, 2026 |
| Registry record updated | January 13, 2026 |
| Trial ID | NCT05766553 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 75 who smoke 10 to 40 cigarettes per day and have a substance use disorder as defined by DSM5 criteria.
✕Probably not a fit
Patients with significant cognitive disorders, other substance addictions, or serious medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of mindfulness meditation conducted in a virtual reality environment on reducing cravings and preventing smoking relapse in individuals with tobacco use disorder. Participants will be randomly assigned to either a group receiving six weekly virtual reality meditation sessions or a control group receiving standard nicotine replacement therapies. The primary goal is to determine if the virtual reality mindfulness approach can lead to sustained smoking cessation for over 30 days. Follow-up assessments will occur at three and six months post-intervention to evaluate relapse rates.
Why it matters
Potential benefit: If successful, this approach could provide a novel, non-drug method for individuals seeking to quit smoking and manage cravings effectively.
How similar studies have gone: While mindfulness and virtual reality have been explored separately in smoking cessation, this specific combination is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any patient consuming 10 to 40 cigarettes per day * Woman or man aged 18 to 75 inclusive * Substance use disorder according to the DSM5 classification * Benefit from social security or benefit from it through a third party in accordance with French law on research involving the human person * Having signed the informed consent form after having received written information. Exclusion Criteria: * Disabling cognitive disorders * Patient under 18 or over 75 years old. * Patient with a psychological disorder or a psychiatric pathology requiring specialized follow-up * Patient with addiction to another product. * Cardiological pathologies that could compromise the participation of patients, detected by an ECG (only for patients who will be randomized in the experimental group). * Advanced pulmonary, renal, and hepatic diseases, or any unstable and serious medical conditions that could compromise the patient's participation in the study, subject to the judgment of the doctor * Pregnant or breastfeeding woman * Simultaneous participation in another trial * Employee of the investigator or of the clinical trial site * Patients protected by law * Patients who do not speak the French language * People not covered by state health insurance * Patients who in the opinion of the investigator are unable to complete the questionnaires * Patient claustrophobic or anxious about using the cabin * Patient allergic to a molecule present in nicotine substitutes
Where it's running
-
Cabinet Médical
Iteuil, France Recruiting -
Cabinet médical des Couronneries
Poitiers, France Recruiting -
Centre Hospitalier Henri Laborit
Poitiers, France Recruiting
Study contacts
- Study coordinator: Nematollah JAAFARI
- Email: nemat.jaafari@ch-poitiers.fr
- Phone: +33 5 16 52 61 18
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized brain-targeted TMS for smoking cessation
A personalized brain-guided Transcranial Magnetic Stimulation (TMS) approach is tested against a standard TMS method to see if it better changes reward brain activity and reduces cravings and smoking in adults with tobacco use disorder.
-
Multilevel program to increase LDCT lung cancer screening and help African American smokers quit
This program will try combining low-dose CT screening with culturally tailored smoking-cessation support to help African American smokers who are eligible for LDCT quit and get screened.
-
TUBSIS 2.0 — an online program to help adults reduce or quit smoking and vaping
This program tests whether a free, anonymous, 4-week web-based course using mindfulness, self-compassion, and behavior-change techniques helps German-, English-, and Turkish-speaking adults who smoke or vape reduce or quit tobacco.
-
Impact of Menthol vs. Non-Menthol Cigarettes on Abuse Liability
This study tests whether menthol cigarettes have different abuse potential than non-menthol cigarettes in menthol cigarette users, using a within-subject design across lab sessions and daily diaries.
-
Ear acupressure plus nicotine replacement to ease withdrawal in psychiatric inpatients
This study will test whether adding ear acupressure (ear seeds) to standard nicotine replacement therapy helps psychiatric inpatients who must stop smoking reduce withdrawal symptoms, cravings, and anxiety.
-
Facilitating Tobacco Treatment in Veterans with Serious Mental Illness
This project tests an external facilitation approach to help VA clinics prescribe smoking medications more often to Veterans with serious mental illness who smoke.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.